Roth Capital Upgrades QLT Inc (QLTI) to Buy

Go back to Roth Capital Upgrades QLT Inc (QLTI) to Buy

QLT Announces Multiple Transactions Designed to Transform the Company and Create Significant Near- and Long-Term Value for Shareholders

June 8, 2015 10:49 AM EDT

QLT to Acquire InSite Vision to Create a Diversified, Pure-Play, Late-Stage Ophthalmic Pharmaceutical Company

Combined Company Will Be Well-Capitalized with a Cash Balance of Approximately $70 Million, Including Newly Invested Capital from Broadfin Capital, JW Asset Management and EcoR1 Capital

QLT to Issue $25 Million of Redeemable Convertible Notes to Shareholders, Providing Them with the Option of Near-Term Liquidity or Participation in the Future of QLT

QLT, Deerfield and Other Leading Healthcare Investors to Invest in Aralez Pharmaceuticals, a Newly Formed, Exceptionally Managed, Commercial-Stage, Irish-Domiciled,... More